Update on alpha-1 antitrypsin deficiency: new therapies

Lomas, D.A. and Hurst, J.R. and Gooptu, Bibekbrata (2016) Update on alpha-1 antitrypsin deficiency: new therapies. Journal of Hepatology 65 (2), pp. 413-424. ISSN 0168-8278.

Full text not available from this repository.

Official URL: http://doi.org/10.1016/j.jhep.2016.03.010

Abstract

α1-antitrypsin deficiency is characterised by the misfolding and intracellular polymerisation of mutant α1-antitrypsin within the endoplasmic reticulum of hepatocytes. The retention of mutant protein causes hepatic damage and cirrhosis whilst the lack of an important circulating protease inhibitor predisposes the individuals with severe α1-antitrypsin deficiency to early onset emphysema. Our work over the past 25 years has led to new paradigms for the liver and lung disease associated with α1-antitrypsin deficiency. We review here the molecular pathology of the cirrhosis and emphysema associated with α1-antitrypsin deficiency and show how an understanding of this condition provided the paradigm for a wider group of disorders that we have termed the serpinopathies. The detailed understanding of the pathobiology of α1-antitrypsin deficiency has identified important disease mechanisms to target. As a result, several novel parallel and complementary therapeutic approaches are in development with some now in clinical trials. We provide an overview of these new therapies for the liver and lung disease associated with α1-antitrypsin deficiency.

Metadata

Item Type:	Article
Keyword(s) / Subject(s):	Serpins, Cirrhosis, Emphysema, Therapeutic strategies, Polymerisation
School:	Birkbeck Faculties and Schools > Faculty of Science > School of Natural Sciences
Depositing User:	Administrator
Date Deposited:	11 May 2016 14:37
Last Modified:	02 Aug 2023 17:23
URI:	https://eprints.bbk.ac.uk/id/eprint/15140

Statistics

Archive Staff Only (login required)

Edit/View Item